I 
119TH CONGRESS 
1ST SESSION H. R. 6664 
To establish a Biotechnology Management Office in the Department of De-
fense and to provide support for the research and development of bio-
industrial manufacturing processes, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 11, 2025 
Mr. NEGUSE introduced the following bill; which was referred to the 
Committee on Armed Services 
A BILL 
To establish a Biotechnology Management Office in the De-
partment of Defense and to provide support for the 
research and development of bioindustrial manufacturing 
processes, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. BIOTECHNOLOGY MANAGEMENT OFFICE. 
(a) DESIGNATION OF SENIOR OFFICIAL.—Not later 
than 90 days after the date of the enactment of this Act, 
the Secretary of Defense shall designate a senior official, 
with relevant biotechnology experience, from a position 
VerDate Sep 11 2014 
01:11 Dec 31, 2025
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6664.IH
H6664
kjohnson on DSK7ZCZBW3PROD with $$_JOB
within the Department of Defense that was in effect on 
the day before the date of the enactment of this Act, to— 
(1) be the senior official for biotechnology 
issues; 
(2) be the head of the Biotechnology Manage-
ment Office established under subsection (b); and 
(3) carry out the responsibilities for the office 
in subsection (c). 
(b) ESTABLISHMENT OF BIOTECHNOLOGY MANAGE-
MENT OFFICE.—Not later than 120 days after the date 
of the enactment of this Act, the Secretary of Defense 
shall, with input from the senior official designated under 
subsection (a), charter and establish, under the authority, 
direction, and control of the Deputy Secretary of Defense, 
a Biotechnology Management Office to foster the develop-
ment, acquisition, and sustainment of broad-based bio-
technology capabilities for the Department. 
(c) RESPONSIBILITIES.—The office established under 
subsection (b) shall be responsible for the following: 
(1) Maintaining and executing a long-term re-
search, development, acquisition, and sustainment 
roadmap. 
(2) Updating policies and guidance within the 
Department relating to the acquisition, adoption, 
VerDate Sep 11 2014 
01:11 Dec 31, 2025
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6664.IH
H6664
kjohnson on DSK7ZCZBW3PROD with $$_JOB
and transition of biotechnology-based products into 
Department use. 
(3) Coordinating with activities across the De-
partment, the Federal Government, industry, aca-
demia, and international partners relating to bio-
technology. 
(4) Proposing options for streamlining the regu-
latory or acquisition process of the Department. 
(5) Conducting, as may be needed, global com-
petition analyses, net assessment, or forecasting to 
support decisionmakers on biotechnology advances. 
(6) Supporting the development of public-pri-
vate partnerships with academia, industry, and other 
State and local government partners, including 
through the development or fostering of regionally 
focused innovation ecosystems. 
(7) Identifying biotechnology workforce and 
training gaps across the workforce of the Depart-
ment. 
(8) Such other responsibilities as the Secretary 
considers appropriate. 
(d) SUNSET.—This section shall terminate on Sep-
tember 30, 2030. 
(e) BRIEFING.—Not later than 30 days after the des-
ignation of the senior official pursuant to subsection (a), 
VerDate Sep 11 2014 
01:11 Dec 31, 2025
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6664.IH
H6664
kjohnson on DSK7ZCZBW3PROD with $$_JOB
the Secretary shall provide to the congressional defense 
committees a briefing on the proposed scope of the charter 
for the office to be established pursuant to subsection (b), 
as well as implementation plans for preliminary activities 
the office will pursue during the proceeding one-year pe-
riod. 
SEC. 2. SUPPORT FOR RESEARCH AND DEVELOPMENT OF 
BIOINDUSTRIAL 
MANUFACTURING 
PROC-
ESSES. 
Section 215 of the James M. Inhofe National Defense 
Authorization Act for Fiscal Year 2023 (Public Law 117– 
263; 10 U.S.C. 4841 note) is amended— 
(1) by redesignating subsections (d) through (f) 
as subsections (e) through (g), respectively; and 
(2) by inserting after subsection (c) the fol-
lowing new subsection: 
‘‘(d) FUNDING.—Funds authorized to be appro-
priated or otherwise made available to the Department of 
Defense for research, development, test, and evaluation 
may be used to carry out the activities described in sub-
section (c), including the design and construction activities 
described in subsection (c).’’. 
Æ 
VerDate Sep 11 2014 
01:11 Dec 31, 2025
Jkt 069200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H6664.IH
H6664
kjohnson on DSK7ZCZBW3PROD with $$_JOB